Interventional device developer Rubicon Medical has finalized a license agreement for the use of SurModics' advanced hydrophilic coating technology with Rubicon's low-profile embolic protection device, the Rubicon Filter, according to the Salt Lake City-based firm.
Rubicon Filter is designed for use in medical procedures to allow the capture and removal of any dislodged embolic material downstream from a blockage in the bloodstream. The product is a guidewire-based filter that is deployed without the use of a catheter, making it smaller and easier to navigate through blood vessels, Rubicon said.
The developer will be using SurModics' coating technology to enhance the deliverability of the Rubicon Filter with no change to the dimensions of the device, the company said.
By AuntMinnie.com staff writers
December 17, 2004
Related Reading
Rubicon completes European enrollment, February 5, 2004
Rubicon moves facility, expands workforce, December 9, 2003
Rubicon names Woolf as CFO, November 18, 2003
Boston Scientific adds to Rubicon investment, October 30, 2003
Copyright © 2004 AuntMinnie.com
